Position in AMPH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$504,216
-$2,224,766 QoQ
Shares Held
24,986
-82.1% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 209 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in AMPH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. AMPH ranks #27 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
340,275 | $184,371,197 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
3,316,358 | $136,070,166 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
553,068 | $93,214,076 | |
| 4 | VTRS |
Viatris Inc
|
5,658,439 | $89,856,006 | |
| 5 | ZTS |
Zoetis Inc.
|
912,367 | $65,562,688 | |
| 6 | ALKS |
Alkermes plc.
|
1,170,242 | $61,320,679 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
2,950,225 | $52,986,040 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
2,844,583 | $41,218,006 |
All Filings in AMPH
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $504,216 | 24,986 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,728,982 | 139,305 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $697,484 | 26,045 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $253,840 | 9,525 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $587,336 | 20,260 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,017,546 | 27,405 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,381,406 | 28,465 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $1,145,600 | 28,640 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,127,168 | 25,670 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,642,982 | 26,564 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,230,229 | 26,750 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,585,365 | 27,586 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $357,487 | 9,533 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $268,766 | 9,592 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $269,308 | 9,584 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $428,786 | 12,325 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $604,806 | 16,847 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $625,871 | 26,873 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $503,555 | 26,489 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $211,579 | 10,495 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $189,905 | 10,366 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||